MAM
Nielsen//NetRatings launches new online multimedia measurement report
Internet audience measurement and analysis agency Nielsen//NetRatings has announced a new online multimedia measurement report measuring use of content for the three largest proprietary formats, regardless of the media player or environment.
The new report provides online publishers and content providers a better perspective on the encoding and consumption of rich media content to drive technology decisions, form strategic partnerships and affect the sales of rich media advertising.
The company says that as the Web evolves, it is constantly refining our tracking technology to provide deeper, more insightful media measurement. This new report offers enhanced breakdowns of multimedia activity, responding to requests from the industry for more granular information on which to base business decisions.
Due to the new methodology, this report does not permit comparisons to previously published market sizes and positions. The actual market positions and user bases of the tracked companies remain fundamentally the same.
The new report includes:
1. Unique audience and active reach percents for RealMedia, Windows Media and QuickTime
2. Segmented activity with enhanced breakdowns of multimedia consumption into “audio/video” and “images/text” categories
3. Top requested audio/video content
4. An overall Web multimedia unique audience number using the three proprietary formats
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
